Trade BBLGW anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Bone Biologics Corp Warrants (BBLGW) is trading at US$7.19, down 6.01% today as of Aug 28, 10:54 EDT. Over the past 52 weeks, BBLGW has traded between US$3.50 and US$35.95. On Syfe you can trade BBLGW with $0 commission and add it to your watchlist.
| Previous close | US$7.65 |
|---|---|
| 52-week range | US$3.50 – US$35.95 |
| Volume | 1.3K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bone Biologics Corp Warrants
Bone Biologics Corp. operates as a medical device company. It engages in the research and development of bone regeneration in spinal fusion. The firm's core product is NELL-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Year: 2021
Bone Biologics Corp Warrants (BBLGW) stock is trading at US$7.19, -6.01% from the previous close of US$7.65.
The 52-week high for Bone Biologics Corp Warrants (BBLGW) stock is US$35.95.
The 52-week low for Bone Biologics Corp Warrants (BBLGW) stock is US$3.50.
Bone Biologics Corp Warrants (BBLGW) does not currently pay a dividend.
Stay on top of BBLGW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
